Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial
- Resource Type
- Article
- Authors
- van der Ree, Meike H; de Vree, J Marleen; Stelma, Femke; Willemse, Sophie; van der Valk, Marc; Rietdijk, Svend; Molenkamp, Richard; Schinkel, Janke; van Nuenen, Ad C; Beuers, Ulrich; Hadi, Salah; Harbers, Marten; van der Veer, Eva; Liu, Kai; Grundy, John; Patick, Amy K; Pavlicek, Adam; Blem, Jacqueline; Huang, Michael; Grint, Paul; Neben, Steven; Gibson, Neil W; Kootstra, Neeltje A; Reesink, Hendrik W
- Source
- In The Lancet 18-24 February 2017 389(10070):709-717
- Subject
- Primary Research
Articles
- Language
- ISSN
- 0140-6736